Category: applied microbiol biotechnol

Caught Our Notice: Forgot to make your article open access? It’ll cost you (with a correction)

Via Wikimedia

Title: Industrial antifoam agents impair ethanol fermentation and induce stress responses in yeast cells

What Caught Our Attention: When authors decide they want to make their articles freely available after they’ve already been published, how should publishers indicate the change, if at all? Recently, Ross Mounce (@rmounce) thought it was odd a Springer journal issued a formal correction notice when the authors wanted to make their paper freely available, and we can’t say we disagree.  As he posted on Twitter:

Continue reading Caught Our Notice: Forgot to make your article open access? It’ll cost you (with a correction)

Author who previously claimed plagiarism was a mistake earns new erratum

A biotechnology journal has corrected a 2006 paper after discovering duplication and plagiarism.

This offense is the second we know of for the corresponding author, Uttam Chand Banerjee, in the same journal, Applied Microbiology and Biotechnology. Last year, Banerjee—who works at National Institute of Pharmaceutical Education and Research (NIPER) in Mohali, Punjab, India—had a 14-year-old review retracted in Applied Microbiology and Biotechnology after an investigation revealed the authors had plagiarized from numerous sources and failed to reference them. At the time, Banerjee told us that he and his co-authors took a few lines from other reviews and that omitting the references was “simply unintentional.” According to The Indian Express, Banerjee also faced plagiarism allegations in 2005, and was denied a prestigious fellowship in 2011 as a result. Continue reading Author who previously claimed plagiarism was a mistake earns new erratum

Biotech journal pulls well-cited review that plagiarized from several sources

Applied Microbiology and BiotechnologyA biotechnology journal has retracted a 14-year-old review after an investigation concluded that the authors had plagiarized from numerous sources.  

The last author of the paper — which has been cited 289 times, according to Thomson Reuters Web of Science — told us the authors took a few lines from other reviews, and unintentionally left off the references.

In June 2011, the same author was denied a prestigious fellowship after an anonymous plagiarism allegation was filed against him. 

Here’s the retraction notice in Applied Microbiology and Biotechnology for “The nitrile-degrading enzymes: current status and future prospects:” Continue reading Biotech journal pulls well-cited review that plagiarized from several sources

A bacterium may be anti-fungal, but it’s not anti-retraction

6

The authors of a paper on an anti-fungal bacterium couldn’t ward off a very common problem: plagiarism. The people credited on the paper, published in Applied Microbiology and Biotechnology, apparently weren’t the original authors, according to the retraction note.

We’re not sure who the original authors are. The retraction note doesn’t elaborate much:

Continue reading A bacterium may be anti-fungal, but it’s not anti-retraction

De-coli: Plagiarism leads to retraction of highly cited recombinant protein paper

appliedmicrobioThe authors of a 2005 article on E. coli in Applied Microbiology and Biotechnology have lost the paper because they recombined it from previous work.

The article, titled “Strategies for efficient production of heterologous proteins in Escherichia coli,” came from a pair of biochemical engineers from the Indian Institute of Technology-Delhi, in New Delhi, India.

According to the abstract: Continue reading De-coli: Plagiarism leads to retraction of highly cited recombinant protein paper

Paper by Bristol-Myers Squibb researchers retracted for “unsolved legal reasons”

applied micro biotechA group of researchers at Bristol-Myers Squibb has had a paper retracted for reasons we can’t quite figure out.

All the notice for “Simultaneous expression of antibody light and heavy chains in Pichia pastoris: improving retransformation outcome by linearizing vector at a different site,” published in Applied Microbiology and Biotechnology, says is: Continue reading Paper by Bristol-Myers Squibb researchers retracted for “unsolved legal reasons”